Efficacy, Immunogenicity and Safety of adjuvanted Herpes Zoster-Virus Subunit Vaccine Candidates in Adults from 60 Years and older: Results from the Efficacy Studies ZOE-50 and ZOE-70Show others and affiliations
2018 (English)In: Der Internist, ISSN 0020-9554, E-ISSN 1432-1289, Vol. 59, p. S64-S65Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
SPRINGER , 2018. Vol. 59, p. S64-S65
National Category
Public Health, Global Health, Social Medicine and Epidemiology
Identifiers
URN: urn:nbn:se:bth-16918ISI: 000439917500146OAI: oai:DiVA.org:bth-16918DiVA, id: diva2:1240303
2018-08-212018-08-212018-08-21Bibliographically approved